PFRDA consults on adopting dual valuation (Accrual/MTM) for Government Securities in NPS/APY schemes to stabilize NAV, reduce ...

With Credit blowups pressuring markets, we'll now see the typical dynamic where news/analysis follows market direction. Read ...

Deciding what to do with Accenture stock right now? You are not alone. With the shares closing at $238.39, investors are ...

Lenskart’s IPO marks a comeback for India’s founder-led startups as Peyush Bansal bets on global expansion, AI eyewear, and ...

Deciding what to do with UnitedHealth Group stock right now? You are definitely not alone. After a rocky year filled with ...

Value Line, Inc. (NASDAQ: VALU) announced today that its Board of Directors declared on October 17, 2025 a quarterly cash dividend of $0.325 per common share, payable on November 10, 2025, to ...

The traditional corporate playbook risks not only underperformance, but a breach of fiduciary duty as cash reserves bleed ...

The average analyst price target of $336.62 suggests approximately 16% upside from current levels, though this represents a significant decline from the stock’s recent highs above $345. Despite Friday ...

The crypto market has entered a defining phase, a transition from mature giants to next-generation innovators. Bitcoin, ...

Oracle shares fell over 7% despite a new Meta partnership, as investors focused on rising costs and execution risks.

Porsche’s decision to prepare former McLaren executive Michael Leiters as its prospective new CEO marks more than a change in leadership.

Third, ATM programs, which we've already discussed. The reflexive loop is clear: hype the narrative, stock trades above NAV, ...